Hans J. Schramm

1.1k total citations
48 papers, 916 citations indexed

About

Hans J. Schramm is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Hans J. Schramm has authored 48 papers receiving a total of 916 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 12 papers in Infectious Diseases and 11 papers in Organic Chemistry. Recurrent topics in Hans J. Schramm's work include HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (11 papers) and Enzyme Structure and Function (8 papers). Hans J. Schramm is often cited by papers focused on HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (11 papers) and Enzyme Structure and Function (8 papers). Hans J. Schramm collaborates with scholars based in Germany, Austria and France. Hans J. Schramm's co-authors include Wolfgang Schramm, W. Hoppe, Jürgen Gassmann, William Lawson, Luc Quéré, Peter M. Colman, M. Steinkilberg, E Jaeger, Andreas Billich and Hideki Nakashima and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Molecular Biology and Biochemical and Biophysical Research Communications.

In The Last Decade

Hans J. Schramm

47 papers receiving 853 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hans J. Schramm Germany 18 507 242 228 147 129 48 916
Sanjeev Munshi United States 26 981 1.9× 446 1.8× 237 1.0× 20 0.1× 119 0.9× 41 2.1k
Alfred M. Engel Germany 20 893 1.8× 106 0.4× 89 0.4× 36 0.2× 73 0.6× 39 1.7k
Lesley A. Earl United States 15 950 1.9× 93 0.4× 81 0.4× 387 2.6× 52 0.4× 18 1.5k
Alan Merk United States 16 1.4k 2.8× 122 0.5× 158 0.7× 632 4.3× 98 0.8× 20 2.1k
Andreas F.‐P. Sonnen Germany 18 871 1.7× 93 0.4× 17 0.1× 107 0.7× 59 0.5× 32 1.4k
Benjamin A. Barad United States 7 720 1.4× 137 0.6× 47 0.2× 176 1.2× 66 0.5× 12 1.0k
David G. Waterman United Kingdom 16 1.1k 2.2× 94 0.4× 27 0.1× 125 0.9× 53 0.4× 35 1.8k
M.G. Rossmann United States 17 691 1.4× 233 1.0× 13 0.1× 100 0.7× 43 0.3× 30 1.3k
Rubén Sánchez-García Spain 11 760 1.5× 120 0.5× 19 0.1× 163 1.1× 52 0.4× 28 1.2k
James M. Parkhurst United Kingdom 11 695 1.4× 75 0.3× 19 0.1× 86 0.6× 61 0.5× 32 1.2k

Countries citing papers authored by Hans J. Schramm

Since Specialization
Citations

This map shows the geographic impact of Hans J. Schramm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans J. Schramm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans J. Schramm more than expected).

Fields of papers citing papers by Hans J. Schramm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans J. Schramm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans J. Schramm. The network helps show where Hans J. Schramm may publish in the future.

Co-authorship network of co-authors of Hans J. Schramm

This figure shows the co-authorship network connecting the top 25 collaborators of Hans J. Schramm. A scholar is included among the top collaborators of Hans J. Schramm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans J. Schramm. Hans J. Schramm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schramm, Hans J. & Wolfgang Schramm. (2005). Suicide Inhibition of HIV and HTLV Proteases by Oligomers of Interface Targeting Peptides. 2005(Fall). 2 indexed citations
2.
Schramm, Hans J.. (2002). Dimerization inhibitors of HIV-1 protease. 2002(Fall). 2 indexed citations
3.
Caflisch, Amedeo, Hans J. Schramm, & Martin Karplus. (2000). Design of dimerization inhibitors of HIV-1 aspartic proteinase: A computer-based combinatorial approach. Journal of Computer-Aided Molecular Design. 14(2). 161–179. 21 indexed citations
4.
Schramm, Hans J., et al.. (1999). Lipopeptides as Dimerization Inhibitors of HIV-1 Protease. Biological Chemistry. 380(5). 593–596. 48 indexed citations
5.
Dornmair, Klaus, et al.. (1997). Screening of Inhibitors of HIV-1 Protease Using anEscherichia coliCell Assay. Biochemical and Biophysical Research Communications. 233(1). 36–38. 10 indexed citations
6.
Schramm, Hans J., Walter Göhring, E Jaeger, et al.. (1996). The inhibition of human immunodeficiency virus proteases by ‘interface peptides’. Antiviral Research. 30(2-3). 155–170. 73 indexed citations
7.
Quéré, Luc, et al.. (1996). Triterpenes as Potential Dimerization Inhibitors of HIV-1 Protease. Biochemical and Biophysical Research Communications. 227(2). 484–488. 65 indexed citations
8.
Meier, Ute‐Christiane, Josef Kellermann, Karlheinz Mann, et al.. (1994). The Cleavage of the Bait Region of α2‐Macroglobulin by Human Immunodeficiency Virus Proteinases and by Astacin. Annals of the New York Academy of Sciences. 737(1). 431–433. 3 indexed citations
9.
Schramm, Hans J., Andreas Billich, E Jaeger, et al.. (1993). The Inhibition of HIV-1 Protease by Interface Peptides. Biochemical and Biophysical Research Communications. 194(2). 595–600. 45 indexed citations
10.
Schramm, Hans J., et al.. (1991). HIV-1 reproduction is inhibited by peptides derived from the N- and C-termini of HIV-1 protease. Biochemical and Biophysical Research Communications. 179(2). 847–851. 60 indexed citations
11.
Billich, Andreas, et al.. (1991). Cleavage of phosphorylase kinase and calcium-free calmodulin by HIV-1 protease. Biochemical and Biophysical Research Communications. 178(3). 892–898. 7 indexed citations
12.
13.
Schramm, Hans J. & Walter Witke. (1988). Electron Microscopical Localization of the α2-Macroglobulin Thiol Ester Sites. Biological Chemistry Hoppe-Seyler. 369(2). 1151–1156. 6 indexed citations
14.
Zimmermann, Thomas, Friedrich Giffhorn, Hans J. Schramm, & Frank Mayer. (1982). Analysis of Structure‐Function Relationships in Citrate Lyase Isolated from Rhodopseudomonas gelatinosa as Revealed by Cross‐linking and Immunoelectron Microscopy. European Journal of Biochemistry. 126(1). 49–56. 6 indexed citations
15.
Colman, Peter M., Hans J. Schramm, & J.M. Guss. (1977). Crystal and molecular structure of the dimer of variable domains of the Bence-Jones protein ROY. Journal of Molecular Biology. 116(1). 73–79. 36 indexed citations
16.
Bösterling, Bernhard, Jürgen Engel, A. Steinemann, & Hans J. Schramm. (1976). Extrinsic Signals for Monitoring the Association Reaction of Proteins as Introduced by Fluorescent and Non-Fluorescent Labels. Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 357(2). 1283–1296. 3 indexed citations
17.
Langer, R., et al.. (1975). Electron microscopy of thin protein crystal sections. Journal of Molecular Biology. 93(2). 159–165. 23 indexed citations
18.
Hoppe, W., et al.. (1974). Three-dimensional reconstruction of individual negatively stained yeast fatty-acid synthetase molecules from tilt series in the electron microscope.. PubMed. 355(11). 1483–7. 62 indexed citations
19.
Schramm, Hans J.. (1971). Die Isolierung und Kristallisation des variablen Fragments eines BENCE-JONES-Proteins. Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 352(2). 1134–1138. 9 indexed citations
20.
Schramm, Hans J.. (1967). Die Verwendung von Imidsäureestern zur chemischen Modifikation von Proteinen, I. Synthese von farbigen Nitrilen, Dinitrilen und bifunktionellen Imidsäureestern. Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 348(Jahresband). 289–292. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026